Dr. Duncan Mwangi | Research Director and Head, Mechanistic Biology (Systems Biology, Immunology and Adjuvant Research), Global Therapeutics Research, Zoetis
Dr. Duncan Mwangi is a Research Director and Head of GTR- Mechanistic Biology within Global Therapeutics Research (GTR), Zoetis R&D, Kalamazoo, Michigan. He is also a member of Zoetis GTR leadership team. He joined Pfizer Animal Health (predecessor of Zoetis) to build the Adjuvant Research Team and support vaccine development programs. He currently leads the Mechanistic Biology group in Zoetis that focusses on identification/development of novel therapeutics, immunomodulators and vaccine adjuvants. Dr. Mwangi is a leader on understanding the mechanisms by which the innate immune system regulates adaptive immunity and harnessing such mechanisms in the design of novel adjuvants, vaccines and therapeutics. Prior to joining Pfizer Animal Health, Dr. Mwangi was a scientist at the International Livestock Research Institute (ILRI, formerly ILRAD, Nairobi, Kenya) leading several programs in immunology, vaccine antigen identification and adjuvants/delivery systems. Prior to joining ILRI, Dr. Mwangi was a post-doctoral immunologist at International Laboratory for Research in Animal Diseases (ILRAD, Nairobi) and the University of Florida focusing on understanding the immunobiology and identification of candidate vaccines for infectious diseases. Dr Mwangi’s research is published in front line journals such as Infection and Immunity, Parasite Immunology, PNAS, Vaccine, Veterinary Immunology and Immunopathology. Furthermore, he has served on editorial boards, and is a reviewer for several Vaccine and Immunology journals. Dr. Mwangi received his Veterinary degree and MSc degree (Immuno-parasitology) from University of Nairobi, Kenya, and holds a PhD (Immunology) from the University of Edinburgh, Scotland, UK.